---
document_datetime: 2026-01-23 12:54:53
document_pages: 11
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/simbrinza-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: simbrinza-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 21.0447952
conversion_datetime: 2026-01-26 20:20:28.351375
docling_version:
  docling-serve: 1.10.0
  docling-jobkit: 1.8.1
  docling: 2.70.0
  docling-core: 2.60.2
  docling-ibm-models: 3.11.0
  docling-parse: 4.7.3
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
<!-- image -->

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number   | Scope                                        | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|----------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| Article 61(3) /      | - Notification acc. Article 61(3) - Accepted | 01/09/2025                          |                                             | PL                               |           |

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/N/0000294245                      | Update of the package leaflet with revised contact details of local representatives.                                                                                                                                                                                                                                                                                                                                                                                                                                       |            |     |                   |
|---------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-------------------|
| Variation type IB /                   | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. B.I.a.1 Change in the manufacturer of a starting material/reagent/intermediate used in the manufacturing process of the active substance or change in the manufacturer (including where relevant quality control testing sites) of the active substance, where no Ph. Eur. Certificate of Suitability is part of the approved dossier - B.I.a.1.z Other variation - Accepted | 17/07/2025 | N/A | EMA/VR/0000266776 |
| Variation type IB / EMA/VR/0000258106 | This was an application for a group of variations. B.II.e.6 Change in any part of the (primary) packaging material not in contact with the finished product formulation (such as colour of flip-off caps, colour code rings on ampoules, change of needle shield (different plastic used)) - B.II.e.6.z Other changes - Accepted                                                                                                                                                                                           | 02/05/2025 | N/A |                   |

<div style=\"page-break-after: always\"></div>

| addition of a new container - B.II.e.1.b.3 Deletion of an immediate packaging container that does not lead to the complete deletion of a strength or pharmaceutical form - Accepted B.II.e.7 Change in supplier of packaging components or devices (when mentioned in the dossier) - B.II.e.7.a Deletion of a supplier - Accepted B.II.e.7 Change in supplier of packaging components or devices (when mentioned in the dossier) - B.II.e.7.a Deletion of a supplier - Accepted B.II.e.7 Change in supplier of packaging components or devices (when mentioned in the dossier) - B.II.e.7.a Deletion of a supplier - Accepted B.II.e.7 Change in supplier of packaging components or devices (when mentioned in the dossier) - B.II.e.7.a Deletion of a supplier - Accepted B.II.e.3 Change in test procedure for the immediate packaging of the finished product - B.II.e.3.c Deletion of a test procedure if an alternative test procedure is already   |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

|                                       | B.II.e.2 Change in the specification parameters and/or limits of the immediate packaging of the finished product - B.II.e.2.z Other changes - Accepted B.II. FINISHED PRODUCT - B.II.z Other variation - Accepted                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |            |     |
|---------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| Variation type IB / EMA/VR/0000262152 | This was an application for a group of variations. B.I.b.1 Change in the specification parameters and/or limits of an active substance, starting material / intermediate / reagent used in the manufacturing process of the active substance - B.I.b.1.d Deletion of a non-significant specification parameter (e.g. deletion of an obsolete parameter) - Accepted B.I.b.1 Change in the specification parameters and/or limits of an active substance, starting material / intermediate / reagent used in the manufacturing process of the active substance - B.I.b.1.d Deletion of a non-significant specification parameter (e.g. deletion of an obsolete parameter) - Accepted B.I.b.1 Change in the specification | 30/04/2025 | N/A |

<div style=\"page-break-after: always\"></div>

| substance, starting material / intermediate / used in the manufacturing process   |
|-----------------------------------------------------------------------------------|
| reagent                                                                           |
| of the active substance - B.I.b.1.b                                               |
| Tightening of specification limits - Accepted                                     |
| B.I.a.1 Change in the manufacturer of a                                           |
| starting material/reagent/intermediate used                                       |
| in the manufacturing process of the active                                        |
| substance or change in the manufacturer                                           |
| (including where relevant quality control                                         |
| testing sites) of the active substance, where                                     |
| no Ph. Eur. Certificate of Suitability is part of                                 |
| the approved dossier - B.I.a.1.z Other                                            |
| variation - Accepted                                                              |
| A. ADMINISTRATIVE CHANGES - A.7                                                   |
| Deletion of manufacturing sites for an active                                     |
| substance, intermediate or finished product,                                      |
| packaging site, manufacturer responsible for                                      |
| batch release, site where batch control takes                                     |
| place, or supplier of a starting material,                                        |
| reagent or excipient (when mentioned in the                                       |
| dossier)* - Accepted                                                              |
| A. ADMINISTRATIVE CHANGES - A.4 Change                                            |
| in the name and/or address of: a                                                  |
| manufacturer (including where relevant                                            |
| quality control testing sites); or an ASMF                                        |
| holder; or a supplier of the active substance,                                    |
| starting material, reagent or intermediate                                        |
| used in the manufacture of the active                                             |
| substance (where specified in the technical                                       |

<div style=\"page-break-after: always\"></div>

| dossier) where no Ph. Eur. Certificate of Suitability is part of the approved dossier; or a manufacturer of a novel excipient (where specified in the technical dossier) - Accepted  A. ADMINISTRATIVE CHANGES - A.4 Change in the name and/or address of: a manufacturer (including where relevant quality control testing sites); or an ASMF holder; or a supplier of the active substance, starting material, reagent or intermediate used in the manufacture of the active substance (where specified in the technical dossier) where no Ph. Eur. Certificate of Suitability is part of the approved dossier; or a manufacturer of a novel excipient (where specified in the technical dossier) - Accepted  A. ADMINISTRATIVE CHANGES - A.4 Change in the name and/or address of: a manufacturer (including where relevant quality control testing sites); or an ASMF holder; or a supplier of the active substance, starting material, reagent or intermediate used in the manufacture of the active substance (where specified in the technical dossier) where no Ph. Eur. Certificate of Suitability is part of the approved dossier; or a manufacturer of a novel excipient (where specified in the technical dossier) - Accepted  B.I.a.2 Changes in the manufacturing   |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

| process of the active substance - B.I.a.2.a Minor change in the manufacturing process of the active substance - Accepted B.I.a.2 Changes in the manufacturing process of the active substance - B.I.a.2.a Minor change in the manufacturing process of the active substance - Accepted B.I.a.2 Changes in the manufacturing process of the active substance - B.I.a.2.a Minor change in the manufacturing process of the active substance - Accepted B.I.a.2 Changes in the manufacturing process of the active substance - B.I.a.2.a Minor change in the manufacturing process of the active substance - Accepted B.I.a.2 Changes in the manufacturing process of the active substance - B.I.a.2.a Minor change in the manufacturing process of the active substance - Accepted B.I.a.2 Changes in the manufacturing process of the active substance - B.I.a.2.a Minor change in the manufacturing process of the active substance - Accepted B.I.b.1 Change in the specification parameters and/or limits of an active substance, starting material / intermediate /   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

| reagent used in the manufacturing process   |
|---------------------------------------------|
| of the active substance - B.I.b.1.z Other   |
| changes - Accepted                          |
| B.I ACTIVE SUBSTANCE - B.I.z Other          |
| variation - Accepted                        |
| B.I.b.2 Change in test procedure for active |
| substance or starting                       |
| material/reagent/intermediate used in the   |
| manufacturing process of the active         |
| substance - B.I.b.2.a Minor changes to an   |
| approved test procedure - Accepted          |
| B.I.b.2 Change in test procedure for active |
| substance or starting                       |
| material/reagent/intermediate used in the   |
| manufacturing process of the active         |
| substance - B.I.b.2.a Minor changes to an   |
| approved test procedure - Accepted          |
| B.I.b.2 Change in test procedure for active |
| substance or starting                       |
| material/reagent/intermediate used in the   |
| manufacturing process of the active         |
| substance - B.I.b.2.a Minor changes to an   |
| approved test procedure - Accepted          |
| B.I.b.2 Change in test procedure for active |
| substance or starting                       |
| material/reagent/intermediate used in the   |
| manufacturing process of the active         |

<div style=\"page-break-after: always\"></div>

|                                       | substance - B.I.b.2.a Minor changes to an approved test procedure - Accepted B.I.a.4 Change to in-process tests or limits applied during the manufacture of the active substance - B.I.a.4.z Other variation - Accepted B.I.a.4 Change to in-process tests or limits applied during the manufacture of the active substance - B.I.a.4.z Other variation - Accepted B.I.a.4 Change to in-process tests or limits applied during the manufacture of the active substance - B.I.a.4.b Addition of a new in- process test and limits - Accepted B.I.a.4 Change to in-process tests or limits applied during the manufacture of the active substance - B.I.a.4.c Deletion of a non- significant in-process test - Accepted B.I.a.4 Change to in-process tests or limits applied during the manufacture of the active substance - B.I.a.4.z Other variation -   |            |     |
|---------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| Variation type IA / EMA/VR/0000266066 | A. ADMINISTRATIVE CHANGES - A.4 Change in the name and/or address of: a manufacturer (including where relevant                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 15/04/2025 | N/A |

<div style=\"page-break-after: always\"></div>

|                                       | quality control testing sites); or an ASMF holder; or a supplier of the active substance, starting material, reagent or intermediate used in the manufacture of the active substance (where specified in the technical dossier) where no Ph. Eur. Certificate of Suitability is part of the approved dossier; or a manufacturer of a novel excipient (where specified in the technical dossier) - Accepted                                                                                                                                                                                                                                                                                                                                                                                                          |            |     |
|---------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| Variation type IB / EMA/VR/0000248411 | B.I.b.2 Change in test procedure for active substance or starting material/reagent/intermediate used in the manufacturing process of the active substance - B.I.b.2.c Other changes to a test procedure (including replacement or addition) for a reagent, which does not have a significant effect on the overall quality of the active substance - Accepted B.I.a.1 Change in the manufacturer of a starting material/reagent/intermediate used in the manufacturing process of the active substance or change in the manufacturer (including where relevant quality control testing sites) of the active substance, where no Ph. Eur. Certificate of Suitability is part of the approved dossier - B.I.a.1.f Changes to quality control testing arrangements for the active substance-replacement or addition of | 11/03/2025 | N/A |

<div style=\"page-break-after: always\"></div>